In last trading session, Atyr Pharma Inc (NASDAQ:ATYR) saw 0.76 million shares changing hands with its beta currently measuring 1.05. Company’s recent per share price level of $3.12 trading at $0.02 or 0.65% at ring of the bell on the day assigns it a market valuation of $236.49M. That closing price of ATYR’s stock is at a discount of -17.95% from its 52-week high price of $3.68 and is indicating a premium of 65.38% from its 52-week low price of $1.08. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.94 million shares which gives us an average trading volume of 744.86K if we extend that period to 3-months.
Atyr Pharma Inc (NASDAQ:ATYR) trade information
Upright in the green during last session for gaining 0.65%, in the last five days ATYR remained trading in the green while hitting it’s week-highest on Thursday, 11/07/24 when the stock touched $3.12 price level, adding 5.17% to its value on the day. Atyr Pharma Inc’s shares saw a change of 121.28% in year-to-date performance and have moved 2.63% in past 5-day. Atyr Pharma Inc (NASDAQ:ATYR) showed a performance of 47.17% in past 30-days. Number of shares sold short was 1.07 million shares which calculate 1.15 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Atyr Pharma Inc (ATYR) estimates and forecasts
Statistics highlight that Atyr Pharma Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 84.62% of value to its shares in past 6 months, showing an annual growth rate of 3.19% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -29.20% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 20k for the same.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 43.36% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 2.58% while estimates for its earnings growth in next 5 years are of 13.00%.
